Benjamin Kornitzer - Apr 18, 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Role
Chief Med. & Quality Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Apr 18, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/29/2022, 06:01 PM
Date Of Original Report
Apr 20, 2022
Previous filing
Sep 29, 2022
Next filing
Apr 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -6.48K -1.2% $0.00 532K Apr 18, 2022 Common Stock 6.48K $4.49 Direct F1
transaction AGL Options (Rights to Buy) Options Exercise $0 -6.3K -1.18% $0.00 526K Apr 19, 2022 Common Stock 6.3K $4.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024.

Remarks:

This Form 4 Amendment corrects the total number of options in this grant beneficially owned by the Reporting Filer, which was inadvertently misstated on the Form 4 filed on April 20, 2022.